Sol-Gel Technologies Ltd. Company Profile
NASDAQ: SLGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:31 AM ET
Sol-Gel Technologies at a glance
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Ness Ziona, Israel. Sol-Gel Technologies is led by Mr. Moshe Arkin and employs about 28 people. The company's shares have traded publicly since 2018.
At a market capitalization of $235.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001684693, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Sol-Gel Technologies do?
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Sol-Gel Technologies Ltd.
- Ticker
- NASDAQ: SLGL
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Moshe Arkin
- Employees
- 28
- Headquarters
- 7 Golda Meir Street, Ness Ziona, Israel
- Phone
- 972 8 931 3433
- Website
- sol-gel.com
- IPO year
- 2018
- Market cap
- $235.55M
- SEC CIK
- 0001684693
Companies similar to Sol-Gel Technologies
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AKBAAkebia Therapeutics Inc. | 0.8484 | -2.86% | $235.10M | vs SLGL |
| CAMPCAMP4 Therapeutics Corporation | 3.70 | -3.64% | $232.21M | vs SLGL |
| ZNTLZentalis Pharmaceuticals Inc. | 2.44 | -4.32% | $239.41M | vs SLGL |
| PYXSPyxis Oncology Inc. | 1.94 | -3.74% | $231.15M | vs SLGL |
| IMRXImmuneering Corporation Class A | 3.71 | -3.89% | $240.03M | vs SLGL |
| QTTBQ32 Bio Inc. | 7.71 | -3.57% | $229.37M | vs SLGL |
| SIGASIGA Technologies Inc. | 3.19 | -2.30% | $228.84M | vs SLGL |
| UPBUpstream Bio Inc. | 4.45 | -3.58% | $243.46M | vs SLGL |